Vanda Pharmaceuticals shares jump 30% after FDA approval of Fanapt for bipolar I disorder

The biopharmaceutical company said Tuesday the latest marketing approval increases the commercial opportunity of the treatment.

Source: Reuters: Health - April 2, 2024 Category: Consumer Health News Source Type: news